Privia Health Group (NASDAQ:PRVA) Earns “Buy” Rating from Truist Financial

Privia Health Group (NASDAQ:PRVA)‘s stock had its “buy” rating reiterated by analysts at Truist Financial in a report issued on Monday,Benzinga reports. They presently have a $31.00 price target on the stock, up from their previous price target of $30.00. Truist Financial’s price objective points to a potential upside of 32.96% from the stock’s previous close.

Other analysts also recently issued research reports about the company. Piper Sandler cut their price target on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. JMP Securities raised their target price on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research note on Friday, August 29th. Weiss Ratings upgraded shares of Privia Health Group from a “sell (d+)” rating to a “hold (c)” rating in a research report on Friday. Barclays lifted their price objective on shares of Privia Health Group from $21.00 to $22.00 and gave the company an “equal weight” rating in a research report on Thursday, October 9th. Finally, Stephens restated an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research report on Wednesday, September 24th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.50.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA traded down $0.11 during midday trading on Monday, hitting $23.32. The company’s stock had a trading volume of 359,567 shares, compared to its average volume of 845,371. Privia Health Group has a 1-year low of $18.77 and a 1-year high of $26.51. The firm’s fifty day moving average price is $24.15 and its 200-day moving average price is $22.76. The firm has a market cap of $2.87 billion, a P/E ratio of 179.28, a P/E/G ratio of 3.32 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The firm had revenue of $213.61 million for the quarter. As a group, research analysts predict that Privia Health Group will post 0.14 earnings per share for the current fiscal year.

Institutional Trading of Privia Health Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. CWM LLC grew its position in Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after buying an additional 604 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Privia Health Group by 2,852.2% in the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after acquiring an additional 2,567 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of Privia Health Group by 2,115.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after purchasing an additional 3,173 shares during the period. Vestcor Inc acquired a new stake in shares of Privia Health Group during the first quarter worth $76,000. Finally, Canada Pension Plan Investment Board lifted its holdings in shares of Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after purchasing an additional 1,200 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.